Blended Interferon-Alpha and Interleukin-2 Preparation from Canada

A mixed solution of recombinant interferon-alpha (IFN-α) and interleukin-2 (IL-2) for immunotherapy in viral infections and cancer. Falls under HTS 3002.14.00 as mixed immunological products (interferons and interleukins) not prepared for retail sale or in measured doses.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

Submit lab reports confirming mixture of immunological proteins like IFN and IL-2, not simple solutions

Ensure cold chain compliance with temperature logs; FDA prior notice required for biological imports